CervoMed CRVO
NASDAQ CRVO
$2.33 +0.04 (+1.79%)
As of: Oct 21, 2026 · 11:40 AM EDT

CervoMed (CRVO) EBITDA Margin (2011 - 2022)

Updated

CervoMed's EBITDA Margin was -11287.77% in Q2 2013, down 8904.25 percentage points from -2383.52% a year earlier.

Analysis

CervoMed (CRVO) EBITDA Margin (2011 - 2022) Analysis & Trends

For FY2012, EBITDA Margin at CervoMed came in at -3141.20%, down 282.26 percentage points from FY2011.

  • In earlier years, EBITDA Margin was -2858.94% in FY2011 (+16020.07 pp) and -18879.01% in FY2010.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn 53.49%
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn 35.95%
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn 49.01%
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn 6.02%
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn -
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 33.11%
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn 46.01%
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn -124.26%
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn 39.16%
10 CervoMed 23.97 Mn -62.05 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 -7,667.09%
Mar 31, 2022 -16,377.61%
Sep 30, 2021 -24,994.87%
Jun 30, 2021 -6,897.67%
Mar 31, 2021 -11,529.81%
Dec 31, 2020 -16,241.39%
Sep 30, 2020 -17,958.91%
Jun 30, 2020 -14,013.97%
Dec 31, 2019 -11,408.27%
Sep 30, 2019 -13,795.94%
Jun 30, 2019 -15,287.71%
Mar 31, 2019 -14,023.27%
Dec 31, 2018 -17,910.59%
Sep 30, 2018 -18,286.72%
Jun 30, 2018 -6,730.94%
Mar 31, 2018 -8,867.32%
Dec 31, 2017 -9,508.27%
Sep 30, 2017 -257,363.13%
Jun 30, 2013 -11,287.77%
Sep 30, 2012 -2,383.52%
API Access

CervoMed EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=CRVO&period=max&api_key=YOUR_API_KEY